Project

Back to overview

European conference for clinical nanomedicine

English title European conference for clinical nanomedicine
Applicant Hunziker Patrick
Number 121208
Funding scheme Scientific Conferences
Research institution Klinik für Intensivmedizin Universitätsspital Basel
Institution of higher education University of Basel - BS
Main discipline Clinical Pharmacology
Start/End 01.05.2008 - 31.10.2008
Approved amount 10'000.00
Show all

All Disciplines (3)

Discipline
Clinical Pharmacology
Biophysics
Biomedical Engineering

Lay Summary (English)

Lead
Lay summary
The European Conference for Clinical Nanomedicine 2008 was the first conference of the European Foundation for Clinical Nanomedicine. It had the aim to bring together an pan-European audience in order to discuss the status of the clinical state of the art of nanomedical practiceNew nanotechnology-based methods, tools and materials with innovative nanoscale properties are being investigated to improve the prevention, early and reliable diagnosis and effective treatment of prevalent and of currently incurable diseases. Successful developments in major research areas such as targeted drug delivery, diagnostic imaging, laboratory diagnostics and monitoring, regenerative medicine and biomaterial implants have shown very promising results. Until now the biomedical evaluation of nanomedical research has largely been limited to cell and animal experiments. An increasing number of products are being tested clinically and some are even reaching the market. Specific challenges are the facilitation of clinical nanomedical research, the assessment of the implications of nanomedicine for the individual and society, and the development of regulatory expertise to adequately assess nanomedicines. The first European Conference for Clinical Nanomedicine installed a strong fundament for the successful collaboration between clinical physicians and academic nanomedicine researchers willing to bring their research to clinical application.The programme started with 4 speeches on the today in medicine unsolved problems that lead to severe illness and death in today’s western world: Oncology, Cardiology, Metabolic Disease and unsolved problems in Diabetes as well as Haematology. Hereafter specialists’ from the technical field and clinicians showed, what nano-scientific technologies are at hand today for solving medical problems. More than 50% of the speakers were MD’s. Since nanomedicine is an outmost complex field and can only be discussed on an interdisciplinary level, the other speakers came from Physics, Chemistry, Biology and materials experts. With 172 Participants from 20 countries of Europe and USA and 3 participants from Japan the organisers reached their goal.- The conference showed well the promise of nanomedical tools, techniques, and materials in the context of prevalent and the unsolved medical problems, e.g. diagnosis and therapy of cancer, cardiovascular disease, inflammation, infection, degenerative and neurological disease, as well as nanomedicine applications for molecular imaging, bedside biomarker testing and monitoring technologies, also addressing questions of toxicity, ethics, societal and environmental impact. As already mentioned above the conference specifically addressed the clinical physicians as well as all nanoscientists with a background of pharmacology, biology, physics and engineering that are involved in development and clinical application of nanomedicine. However the organisers also wanted to create the first steps towards a forum that also is of interest for policymakers, experts from industry in the field of life sciences and involved in the development of new tools and materials for nanomedicine, as well as all those investigating the potential of future emerging technologies.At the dame time the organisers have edited the first issue of the European Journal for Nanomedicine. The second conference, this time with a small foyer-exhibition is announced for April 26-29, 2009, again in Basel.
Direct link to Lay Summary Last update: 21.02.2013

Responsible applicant and co-applicants

-